Consort Medical PLC Total Voting Rights (8788A)
01 10월 2015 - 5:23PM
UK Regulatory
TIDMCSRT
RNS Number : 8788A
Consort Medical PLC
01 October 2015
Registered Number 406711
Consort Medical plc (the "Company")
Total Voting Rights
The Company hereby notifies the market of the following
disclosure with respect to the share capital and voting rights of
the Company:
As at the 30 September 2015, the capital of the Company consists
of 49,130,358 ordinary shares of 10 pence each with voting
rights.
Therefore, the total number of voting rights in the Company is
49,130,358.
Enquiries:
Consort Medical plc
Iain Ward, Company Secretary 01442 867920
Consort Medical plc is a leading, global, single source drug and
delivery device CDMO through its two operating subsidiaries Bespak
and Aesica. Consort Medical is at the leading edge of innovation
and is committed to investing in patient, clinician and customer
driven innovation to create new treatments, new markets and new
opportunities.
Bespak is a global market leader in the manufacture of drug
delivery devices for pharmaceutical partner companies, including
respiratory, nasal, and injectables products, and the manufacture
of devices for the point of care diagnostics market.
Aesica is a leading provider of finished dose and active
pharmaceutical ingredient (API) development and manufacturing
services to pharmaceutical partners.
The Group has facilities in King's Lynn, Cambridge, Nelson,
Milton Keynes, Cramlington, Nottingham, Queenborough and Hemel
Hempstead, UK; in Monheim and Zwickau, Germany; and in Pianezza,
Italy. Consort Medical is a public company quoted on the premium
list of the London Stock Exchange (LSE: CSRT). The Group's website
address is www.consortmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGGGPUUPAURG
(END) Dow Jones Newswires
October 01, 2015 04:23 ET (08:23 GMT)
Bespak (LSE:BPK)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Bespak (LSE:BPK)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
